• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在外科系列中双垂体腺瘤的患病率:临床、组织学和遗传学特征。

Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features.

机构信息

Fondazione Salvatore Maugeri IRCCS, Istituto Superiore Prevenzione e Sicurezza Lavoro, University of Pavia, Italy.

出版信息

J Endocrinol Invest. 2010 May;33(5):325-31. doi: 10.1007/BF03346594. Epub 2009 Dec 1.

DOI:10.1007/BF03346594
PMID:19955848
Abstract

BACKGROUND

The term double pituitary adenomas (DPA) is usually referred to those rare lesions showing two distinct cellular components. Genetic background may sustain the proliferation of more than one cell at the same time but no information is available on the presence of aip mutations in these patients.

AIM

We report the prevalence and the endocrinological, neuroradiological, histopathological and genetic features of DPA detected in a large surgical series. The contribution of pituitary transcription factor immunostains in DPA was also evaluated.

SUBJECTS AND METHODS

One-hundred-forty-four patients undergoing surgery for tumors of the sellar region were evaluated. Histopathology, immunohistochemistry and the mutational analysis for the entire coding region of the AIP and MEN1 genes were performed.

RESULTS

One-hundred-seventeen patients out of 144 had a pituitary adenoma. DPA was found in 3 (2.6%) out of 117 patients with pituitary adenoma. Immunohistochemistry and transcription factors analysis demonstrated two not yet described histotype associations in DPA. The coexistence of somatotroph-lactotroph and silent mammosomatotroph histotype in 1 case and the coexistence of sparsely granulated lactotroph and null cell adenomas in the remaining two cases were first identified. Sequencing data for the coding region of the aip and the menin gene resulted in wild type sequences in all patients with DPA.

CONCLUSIONS

The prevalence of DPA observed in our unselected surgical series is not negligible (2.6%). Furthermore, the evaluation of the treatment outcome would suggest that the clinical management of DPAs requires a careful diagnostic approach and follow- up.

摘要

背景

双垂体腺瘤(DPA)一词通常指的是那些显示出两种不同细胞成分的罕见病变。遗传背景可能会同时维持不止一种细胞的增殖,但目前尚无关于这些患者存在 AIP 突变的信息。

目的

我们报告了在一个大型手术系列中检测到的 DPA 的患病率以及内分泌、神经放射学、组织病理学和遗传学特征。还评估了垂体转录因子免疫染色在 DPA 中的作用。

受试者和方法

评估了 144 例接受鞍区肿瘤手术的患者。进行了组织病理学、免疫组织化学和 AIP 和 MEN1 基因完整编码区的突变分析。

结果

144 例患者中有 117 例患有垂体腺瘤,其中 3 例(2.6%)患有 DPA。免疫组织化学和转录因子分析显示 DPA 存在两种尚未描述的组织型关联。在 1 例中发现了生长激素-催乳素和静默乳突生长激素组织型的共存,在另外 2 例中发现了稀疏颗粒状催乳素和无细胞腺瘤的共存。DPA 患者的 AIP 和 menin 基因编码区测序数据均为野生型序列。

结论

我们在未选择的手术系列中观察到的 DPA 患病率不容忽视(2.6%)。此外,治疗结果的评估表明,DPAs 的临床管理需要仔细的诊断方法和随访。

相似文献

1
Prevalence of double pituitary adenomas in a surgical series: Clinical, histological and genetic features.在外科系列中双垂体腺瘤的患病率:临床、组织学和遗传学特征。
J Endocrinol Invest. 2010 May;33(5):325-31. doi: 10.1007/BF03346594. Epub 2009 Dec 1.
2
Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.巨大垂体腺瘤:病理-影像学相关性及 p53 和 MIB-1 标记物的作用缺失。
Am J Surg Pathol. 2011 Aug;35(8):1204-13. doi: 10.1097/PAS.0b013e31821e8c96.
3
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.对散发型垂体大腺瘤的年轻患者进行遗传学分析:除 AIP 外,不要忘记 MEN1 基因分析。
Eur J Endocrinol. 2013 Mar 15;168(4):533-41. doi: 10.1530/EJE-12-0763. Print 2013 Apr.
4
Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.在一个 443 例患者的前瞻性单中心队列中,散发垂体腺瘤中的种系 AIP 突变:患病率。
J Clin Endocrinol Metab. 2012 Apr;97(4):E663-70. doi: 10.1210/jc.2011-2291. Epub 2012 Feb 8.
5
Prevalence of Gs alpha mutations in Korean patients with pituitary adenomas.韩国垂体腺瘤患者中Gsα突变的患病率。
J Endocrinol. 2001 Feb;168(2):221-6. doi: 10.1677/joe.0.1680221.
6
Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.中国某单一中心的 1 型多发性内分泌肿瘤患者的垂体腺瘤:单中心经验。
Pituitary. 2019 Apr;22(2):113-123. doi: 10.1007/s11102-019-00939-x.
7
Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.人垂体腺瘤中RET和胶质细胞源性神经营养因子(GDNF)基因罕见的可检测体细胞突变
Endocr J. 1999 Feb;46(1):199-207. doi: 10.1507/endocrj.46.199.
8
Genetic mutations in sporadic pituitary adenomas--what to screen for?散发型垂体腺瘤中的基因突变——需要筛查哪些?
Nat Rev Endocrinol. 2015 Jan;11(1):43-54. doi: 10.1038/nrendo.2014.181. Epub 2014 Oct 28.
9
Screening of Gene Variations in a Cohort of Turkish Patients with Young-Onset Sporadic Hormone-Secreting Pituitary Adenomas.对一组患有早发性散发性激素分泌型垂体腺瘤的土耳其患者进行基因变异筛查。
Genet Test Mol Biomarkers. 2018 Dec;22(12):702-708. doi: 10.1089/gtmb.2018.0133. Epub 2018 Nov 21.
10
MEN1 and pituitary adenomas.MEN1 与垂体腺瘤。
Ann Endocrinol (Paris). 2012 Apr;73(2):59-61. doi: 10.1016/j.ando.2012.03.038. Epub 2012 Apr 27.

引用本文的文献

1
Challenges and opportunities for new intraoperative optical techniques in the surgical treatment of pituitary adenomas: a review.垂体腺瘤手术治疗中新型术中光学技术的挑战与机遇:综述
J Biomed Opt. 2025 Aug;30(8):080901. doi: 10.1117/1.JBO.30.8.080901. Epub 2025 Aug 13.
2
Genetic profiling of synchronous pituitary corticotroph adenomas.同步垂体促肾上腺皮质激素腺瘤的基因谱分析
Pituitary. 2025 Jun 22;28(4):77. doi: 10.1007/s11102-025-01549-6.
3
Genetic Profiling of Synchronous Pituitary Corticotroph Adenomas.同步性垂体促肾上腺皮质激素腺瘤的基因谱分析

本文引用的文献

1
Pathology of the human pituitary adenomas.人类垂体腺瘤的病理学
Histochem Cell Biol. 2008 Sep;130(3):495-507. doi: 10.1007/s00418-008-0472-1. Epub 2008 Aug 8.
2
Practical pituitary pathology: what does the pathologist need to know?实用垂体病理学:病理学家需要了解什么?
Arch Pathol Lab Med. 2008 Aug;132(8):1231-40. doi: 10.5858/2008-132-1231-PPPWDT.
3
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.芳烃受体相互作用蛋白基因在家族性和散发性垂体腺瘤中的作用。
Res Sq. 2025 May 5:rs.3.rs-6356485. doi: 10.21203/rs.3.rs-6356485/v1.
4
Double PitNETs: A Case Report and Literature Review.双重垂体神经内分泌肿瘤:病例报告及文献综述
Cancers (Basel). 2025 Feb 17;17(4):675. doi: 10.3390/cancers17040675.
5
Typical morphological characteristics of the immunohistochemical subtypes of pituitary microadenomas: a dual center study.垂体微腺瘤免疫组化亚型的典型形态学特征:一项双中心研究。
Endocr Connect. 2024 Nov 14;13(12). doi: 10.1530/EC-24-0378. Print 2024 Dec 1.
6
Double pituitary adenomas: report of two cases and systematic review of the literature.双重垂体腺瘤:两例报告及文献系统回顾。
Front Endocrinol (Lausanne). 2024 Apr 2;15:1373869. doi: 10.3389/fendo.2024.1373869. eCollection 2024.
7
Double pituitary neuroendocrine tumors in a patient with normal growth hormone level acromegaly: A case report and review of the literature.生长激素水平正常的肢端肥大症患者中的双垂体神经内分泌肿瘤:一例报告并文献复习
Surg Neurol Int. 2023 Dec 15;14:425. doi: 10.25259/SNI_718_2023. eCollection 2023.
8
Consecutive resections of double pituitary adenoma for resolution of Cushing disease: illustrative case.连续切除双垂体腺瘤以治愈库欣病:病例说明
J Neurosurg Case Lessons. 2023 Nov 27;6(22). doi: 10.3171/CASE23485.
9
Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.库欣综合征在 1 型多发性内分泌肿瘤中的表现。
Front Endocrinol (Lausanne). 2023 Jun 20;14:1183297. doi: 10.3389/fendo.2023.1183297. eCollection 2023.
10
A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' Disease.1型垂体转录因子/类固醇生成因子-1阳性双垂体腺瘤与颅咽管瘤并存并伴有格雷夫斯病的碰撞瘤
NMC Case Rep J. 2023 Jun 6;10:169-175. doi: 10.2176/jns-nmc.2022-0396. eCollection 2023.
J Clin Endocrinol Metab. 2008 Jun;93(6):2390-401. doi: 10.1210/jc.2007-2611. Epub 2008 Apr 1.
4
Silent familial isolated pituitary adenomas: histopathological and clinical case report.沉默型家族性孤立性垂体腺瘤:组织病理学及临床病例报告
Endocr Pathol. 2008 Spring;19(1):40-6. doi: 10.1007/s12022-008-9018-2.
5
Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.多发性内分泌腺瘤1型综合征(MEN1)中的垂体肿瘤和增生:一项针对77例患者与2509例非MEN1患者的病例对照研究。
Am J Surg Pathol. 2008 Apr;32(4):534-43. doi: 10.1097/PAS.0b013e31815ade45.
6
Divergence between growth hormone and insulin-like growth factor-i concentrations in the follow-up of acromegaly.肢端肥大症随访中生长激素与胰岛素样生长因子 -I 浓度之间的差异
J Clin Endocrinol Metab. 2008 Apr;93(4):1324-30. doi: 10.1210/jc.2007-2104. Epub 2008 Jan 29.
7
Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.口服葡萄糖耐量试验期间的生长激素反应:检测方法对肢端肥大症患者和健康对照者参考值估计的影响,以及性别、年龄和体重指数的作用。
J Clin Endocrinol Metab. 2008 Apr;93(4):1254-62. doi: 10.1210/jc.2007-2084. Epub 2008 Jan 2.
8
Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncology.
Endocr Pathol. 2007 Spring;18(1):37-41. doi: 10.1007/s12022-007-0008-6.
9
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.一大群散发性肢端肥大症患者中芳烃受体相互作用蛋白基因的种系失活突变:在一部分患有大腺瘤的年轻患者中发现了这些突变。
Eur J Endocrinol. 2007 Jul;157(1):1-8. doi: 10.1530/EJE-07-0181.
10
Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.芳烃受体相互作用蛋白基因突变所致垂体腺瘤易感性的分子诊断
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4101-5. doi: 10.1073/pnas.0700004104. Epub 2007 Feb 28.